ReviewCancers2023
Lung Cancer as a Leading Cause among Paraneoplastic Non-Bacterial Thrombotic Endocarditis: A Meta-Analysis of Individual Patients' Data.
Review in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 23 citations in OpenAlex.
- Stroke in non-bacterial thrombotic endocarditis: a patient-level systematic review of clinical characteristics, management, and outcomes.Frontiers in stroke · 2026Pooled it
- Non-bacterial Thrombotic Endocarditis in Lung Cancer: A Systematic Review.Current cardiology reviews · 2025Pooled it
- Clinical efficacy of lenvatinib, trans-arterial chemoembolization, and PD-1/L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and network meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024Pooled it
- Marantic endocarditis: a multidisciplinary case in which the etymology helps to determine the aetiology.European heart journal. Case reports · 2026Article
- Article
- Cardiac valve mass revealed by venous and arterial embolism: case report and review of the literature.European heart journal. Case reports · 2026Article
- Review
- Article
- Non-bacterial thrombotic endocarditis in ovarian cancer: A systematic review.Gynecologic oncology reports · 2025Review
- Article
- Case Report: Unraveling a web of clots: marantic endocarditis as a paraneoplastic manifestation of lung cancer.Frontiers in oncology · 2025Article
- Clinical insights into nonbacterial thrombotic endocarditis in cancer patients: A case-based systematic review.ARYA atherosclerosis · 2025Review
- Multimodality Imaging Supports Cardiac Lesion Diagnosis in Patient With Liver Carcinoma: A Case Report.Cancer reports (Hoboken, N.J.) · 2024Article
- Non-bacterial thrombotic endocarditis inTranslational lung cancer research · 2024Article
- Systemic embolization due to non-bacterial thrombotic endocarditis: An autopsy case report and mini review of the literature.SAGE open medical case reports · 2024Article
- Diagnostic Work-Up in Patients with Nonbacterial Thrombotic Endocarditis.Journal of clinical medicine · 2023Review
- A Dual-Pathogen Mitral Valve Endocarditis Caused byPathogens (Basel, Switzerland) · 2023Article
- Nonbacterial Thrombotic Endocarditis With Embolic Phenomena Diagnosed by Transesophageal Echocardiogram.Cureus · 2023Article
- Unveiling Lung Adenocarcinoma: Non-bacterial Thrombotic Endocarditis as the Debut Sign.Cureus · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 2 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypercoagulability is strongly associated with cancer and may result in non-bacterial thrombotic endocarditis (NBTE). The aim of our meta-analysis was to explore the demographics and characteristics of this condition in cancer. Databases were systematically searched. The outcomes were to identify the annual trend in premortem diagnosis among the entire cohort and different subgroups and to identify differences in characteristics and survival in the considered population. A total of 121 studies with 144 patients were included. The proportion of marantic endocarditis associated with lung cancer was 0.29 (95% CI, 0.21-0.37;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.